中华皮肤科杂志 ›› 2026, Vol. 59 ›› Issue (10): 961-966.doi: 10.35541/cjd.20260155

• 论著·性传播疾病 • 上一篇    下一篇

苄星青霉素治疗的隐性梅毒患者血清学反应及体液梅毒螺旋体DNA检测

刘迪1,周倩扬1,张瑞丽1,王千秋2   

  1. 1南京医科大学第二附属医院皮肤科,南京  210003;2中国医学科学院北京协和医学院,皮肤病医院  中国疾病预防控制中心性病控制中心  中心办公室,南京  210042
  • 收稿日期:2026-03-23 修回日期:2026-09-12 发布日期:2026-10-07
  • 通讯作者: 张瑞丽;王千秋 E-mail:reallyvictor@126.com;wangqq@ncstdlc.org
  • 基金资助:
    中国医学科学院医学与健康科技创新工程(2021-I2M-1-001)

Serological response and detection of Treponema pallidum DNA in body fluids of patients with latent syphilis treated with benzathine penicillin

Liu Di¹, Zhou Qianyang¹, Zhang Ruili¹, Wang Qianqiu²   

  1. ¹Department of Dermatology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210003, China; ²STD Center Office, National Center for STD Control, Chinese Center for Disease Control and Prevention, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing 210042, China
  • Received:2026-03-23 Revised:2026-09-12 Published:2026-10-07
  • Contact: Zhang Ruili; Wang Qianqiu E-mail:reallyvictor@126.com;wangqq@ncstdlc.org
  • Supported by:
    CAMS Innovation Fund for Medical Sciences(2021-I2M-1-001)

摘要: 【摘要】 目的 观察隐性梅毒患者苄星青霉素治疗后的血清学反应及体液梅毒螺旋体DNA(TP-DNA)水平。方法 回顾性分析2021年8月至2024年12月于南京医科大学第二附属医院皮肤科确诊为隐性梅毒及早期显性梅毒并接受苄星青霉素治疗患者的临床资料,纳入完成12个月随访的病例。治疗前及治疗后第3、6、9、12 个月采集患者的外周血,采用快速血浆反应素试验(RPR)评估血清学反应,以12个月时的检测结果评估最终应答。对自愿接受体液检测的隐性梅毒患者,于治疗前采集外周静脉血、唾液及中段晨尿标本,女性患者另采集阴道后穹窿拭子标本,采用实时荧光定量PCR检测各样本中TP-DNA水平。采用多因素Logistic回归分析隐性梅毒患者血清学应答的影响因素。结果 纳入420例隐性梅毒患者,男195例(46.4%),女225例(53.6%),年龄18 ~ 84(40.36 ± 17.09)岁;其中早期隐性梅毒147例(35.0%),晚期273例(65.0%)。纳入38例早期显性梅毒患者,男26例(68.4%),女12例(31.6%),年龄18 ~ 68(35.24 ± 13.77)岁;其中一期梅毒15例(39.5%),二期23例(60.5%)。隐性梅毒患者中,343例应答(106例治愈,237例有效),应答率81.7%;显性梅毒患者中,36例应答(8例治愈,28例有效),应答率94.7%。单因素Logistic回归分析显示,年龄、疾病分期、初始RPR滴度与隐性梅毒患者12个月血清学应答相关(均P < 0.05);多因素分析显示,年龄 ≥ 45岁和晚期梅毒为预后不良的独立危险因素(均P < 0.05),初始RPR滴度1:16 ~ 1:32为独立保护因素(P < 0.001)。26 例隐性梅毒患者自愿接受体液检测,血清中TP-DNA阳性率最高(11/26例,42.3%),其次为唾液(8/26例,30.8%),阴道拭子(3/16例,18.8%),尿液(4/26例,15.4%)。结论 隐性梅毒对苄星青霉素治疗的血清学应答率较低,年龄 ≥ 45岁及晚期隐性梅毒是应答不佳的独立影响因素,隐性梅毒患者体液中可检出TP-DNA,提示存在潜在传播风险。

关键词: 梅毒, 潜伏, 苍白密螺旋体, 苄星青霉素G, 快速血浆反应素试验, 血清学应答

Abstract: 【Abstract】 Objective To investigate the serological response and Treponema pallidum DNA (TP-DNA) levels in body fluids of patients with latent syphilis after treatment with benzathine penicillin. Methods Clinical data were collected from patients who were diagnosed with latent syphilis or early symptomatic syphilis and treated with benzathine penicillin at the Department of Dermatology, the Second Affiliated Hospital of Nanjing Medical University from August 2021 to December 2024. Patients who had completed 12 months of follow-up were included in the analysis. Peripheral blood samples were collected before treatment and at 3, 6, 9, and 12 months after treatment; the rapid plasma reagin (RPR) test was used to evaluate the serological response, and the results at 12 months were used to assess the final response. For patients with latent syphilis who voluntarily underwent body fluid testing, peripheral venous blood, saliva, and first-morning midstream urine samples were collected before treatment, and posterior fornix swab samples were additionally collected from female patients; real-time fluorescence-based quantitative PCR was performed to detect TP-DNA levels in samples. Multivariate logistic regression analysis was conducted to identify the factors influencing the serological response in patients with latent syphilis. Results A total of 420 patients with latent syphilis were included, comprising 195 males (46.4%) and 225 females (53.6%), aged 18 to 84 (40.36 ± 17.09) years; among them, 147 (35.0%) were diagnosed with early latent syphilis and 273 (65.0%) with late latent syphilis. Thirty-eight patients with early symptomatic syphilis were included, comprising 26 males (68.4%) and 12 females (31.6%), aged 18 to 68 (35.24 ± 13.77) years; among them, 15 (39.5%) were diagnosed with primary syphilis, and 23 (60.5%) with secondary syphilis. Among the patients with latent syphilis, 343 responded (106 cured and 237 with an effective response), with a response rate of 81.7%; among the patients with symptomatic syphilis, 36 responded (8 cured and 28 with an effective response), with a response rate of 94.7%. Univariate logistic regression analysis showed that age, disease stage, and initial RPR titers were associated with the 12-month serological response in patients with latent syphilis (all P < 0.05); multivariate analysis showed that age ≥ 45 years and late syphilis were independently associated with poor prognosis (both P < 0.05), and an initial RPR titer of 1∶16 to 1∶32 was independently associated with a favorable outcome (P < 0.001). Among the 26 patients with latent syphilis who voluntarily underwent body fluid testing, the positive rate of TP-DNA was the highest in sera (11/26, 42.3%), followed by saliva (8/26, 30.8%), vaginal swabs (3/16, 18.8%), and urine (4/26, 15.4%). Conclusions Patients with latent syphilis had a relatively low serological response rate to benzathine penicillin treatment. Age ≥ 45 years and late latent syphilis were independent influencing factors for a poor response. TP-DNA could be detected in the body fluids of patients with latent syphilis, suggesting a potential risk of transmission.

Key words: Syphilis, latent, Treponema pallidum, Penicillin G benzathine, Rapid plasma reagin test, Serological response

引用本文

刘迪 周倩扬 张瑞丽 王千秋. 苄星青霉素治疗的隐性梅毒患者血清学反应及体液梅毒螺旋体DNA检测[J]. 中华皮肤科杂志, 2026,59(10):961-966. doi:10.35541/cjd.20260155

Liu Di¹, Zhou Qianyang¹, Zhang Ruili¹, Wang Qianqiu². Serological response and detection of Treponema pallidum DNA in body fluids of patients with latent syphilis treated with benzathine penicillin[J]. Chinese Journal of Dermatology, 2026, 59(10): 961-966.doi:10.35541/cjd.20260155